List of Tables
Table 1. Global Linagliptin Tablets Market Value Comparison by Type (2024 VS 2031) & (US$ Million)
Table 2. Global Linagliptin Tablets Market Value by Application (2024 VS 2031) & (US$ Million)
Table 3. Global Linagliptin Tablets Market Competitive Situation by Manufacturers in 2024
Table 4. Global Linagliptin Tablets Sales (K Units) of Key Manufacturers (2020-2025)
Table 5. Global Linagliptin Tablets Sales Market Share by Manufacturers (2020-2025)
Table 6. Global Linagliptin Tablets Revenue (US$ Million) by Manufacturers (2020-2025)
Table 7. Global Linagliptin Tablets Revenue Share by Manufacturers (2020-2025)
Table 8. Global Market Linagliptin Tablets Average Price (US$/Unit) of Key Manufacturers (2020-2025)
Table 9. Global Key Players of Linagliptin Tablets, Industry Ranking, 2022 VS 2023 VS 2024
Table 10. Global Key Manufacturers of Linagliptin Tablets, Manufacturing Sites & Headquarters
Table 11. Global Key Manufacturers of Linagliptin Tablets, Product Type & Application
Table 12. Global Key Manufacturers of Linagliptin Tablets, Date of Enter into This Industry
Table 13. Global Manufacturers Market Concentration Ratio (CR5 and HHI)
Table 14. Global Linagliptin Tablets by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Linagliptin Tablets as of 2024)
Table 15. Manufacturers Mergers & Acquisitions, Expansion Plans
Table 16. Global Linagliptin Tablets Market Size by Region (US$ Million): 2020 VS 2024 VS 2031
Table 17. Global Linagliptin Tablets Sales by Region (2020-2025) & (K Units)
Table 18. Global Linagliptin Tablets Sales Market Share by Region (2020-2025)
Table 19. Global Linagliptin Tablets Sales by Region (2026-2031) & (K Units)
Table 20. Global Linagliptin Tablets Sales Market Share by Region (2026-2031)
Table 21. Global Linagliptin Tablets Revenue by Region (2020-2025) & (US$ Million)
Table 22. Global Linagliptin Tablets Revenue Market Share by Region (2020-2025)
Table 23. Global Linagliptin Tablets Revenue by Region (2026-2031) & (US$ Million)
Table 24. Global Linagliptin Tablets Revenue Market Share by Region (2026-2031)
Table 25. North America Linagliptin Tablets Revenue by Country: 2020 VS 2024 VS 2031 (US$ Million)
Table 26. North America Linagliptin Tablets Sales by Country (2020-2025) & (K Units)
Table 27. North America Linagliptin Tablets Sales by Country (2026-2031) & (K Units)
Table 28. North America Linagliptin Tablets Revenue by Country (2020-2025) & (US$ Million)
Table 29. North America Linagliptin Tablets Revenue by Country (2026-2031) & (US$ Million)
Table 30. Europe Linagliptin Tablets Revenue by Country: 2020 VS 2024 VS 2031 (US$ Million)
Table 31. Europe Linagliptin Tablets Sales by Country (2020-2025) & (K Units)
Table 32. Europe Linagliptin Tablets Sales by Country (2026-2031) & (K Units)
Table 33. Europe Linagliptin Tablets Revenue by Country (2020-2025) & (US$ Million)
Table 34. Europe Linagliptin Tablets Revenue by Country (2026-2031) & (US$ Million)
Table 35. Asia Pacific Linagliptin Tablets Revenue by Region: 2020 VS 2024 VS 2031 (US$ Million)
Table 36. Asia Pacific Linagliptin Tablets Sales by Region (2020-2025) & (K Units)
Table 37. Asia Pacific Linagliptin Tablets Sales by Region (2026-2031) & (K Units)
Table 38. Asia Pacific Linagliptin Tablets Revenue by Region (2020-2025) & (US$ Million)
Table 39. Asia Pacific Linagliptin Tablets Revenue by Region (2026-2031) & (US$ Million)
Table 40. Latin America Linagliptin Tablets Revenue by Country: 2020 VS 2024 VS 2031 (US$ Million)
Table 41. Latin America Linagliptin Tablets Sales by Country (2020-2025) & (K Units)
Table 42. Latin America Linagliptin Tablets Sales by Country (2026-2031) & (K Units)
Table 43. Latin America Linagliptin Tablets Revenue by Country (2020-2025) & (US$ Million)
Table 44. Latin America Linagliptin Tablets Revenue by Country (2026-2031) & (US$ Million)
Table 45. Middle East and Africa Linagliptin Tablets Revenue by Country: 2020 VS 2024 VS 2031 (US$ Million)
Table 46. Middle East and Africa Linagliptin Tablets Sales by Country (2020-2025) & (K Units)
Table 47. Middle East and Africa Linagliptin Tablets Sales by Country (2026-2031) & (K Units)
Table 48. Middle East and Africa Linagliptin Tablets Revenue by Country (2020-2025) & (US$ Million)
Table 49. Middle East and Africa Linagliptin Tablets Revenue by Country (2026-2031) & (US$ Million)
Table 50. Global Linagliptin Tablets Sales (K Units) by Type (2020-2025)
Table 51. Global Linagliptin Tablets Sales (K Units) by Type (2026-2031)
Table 52. Global Linagliptin Tablets Sales Market Share by Type (2020-2025)
Table 53. Global Linagliptin Tablets Sales Market Share by Type (2026-2031)
Table 54. Global Linagliptin Tablets Revenue (US$ Million) by Type (2020-2025)
Table 55. Global Linagliptin Tablets Revenue (US$ Million) by Type (2026-2031)
Table 56. Global Linagliptin Tablets Revenue Market Share by Type (2020-2025)
Table 57. Global Linagliptin Tablets Revenue Market Share by Type (2026-2031)
Table 58. Global Linagliptin Tablets Price (US$/Unit) by Type (2020-2025)
Table 59. Global Linagliptin Tablets Price (US$/Unit) by Type (2026-2031)
Table 60. Global Linagliptin Tablets Sales (K Units) by Application (2020-2025)
Table 61. Global Linagliptin Tablets Sales (K Units) by Application (2026-2031)
Table 62. Global Linagliptin Tablets Sales Market Share by Application (2020-2025)
Table 63. Global Linagliptin Tablets Sales Market Share by Application (2026-2031)
Table 64. Global Linagliptin Tablets Revenue (US$ Million) by Application (2020-2025)
Table 65. Global Linagliptin Tablets Revenue (US$ Million) by Application (2026-2031)
Table 66. Global Linagliptin Tablets Revenue Market Share by Application (2020-2025)
Table 67. Global Linagliptin Tablets Revenue Market Share by Application (2026-2031)
Table 68. Global Linagliptin Tablets Price (US$/Unit) by Application (2020-2025)
Table 69. Global Linagliptin Tablets Price (US$/Unit) by Application (2026-2031)
Table 70. Boehringer Ingelheim Company Information
Table 71. Boehringer Ingelheim Description and Business Overview
Table 72. Boehringer Ingelheim Linagliptin Tablets Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2020-2025)
Table 73. Boehringer Ingelheim Linagliptin Tablets Product
Table 74. Boehringer Ingelheim Recent Developments/Updates
Table 75. Eli Lilly Company Information
Table 76. Eli Lilly Description and Business Overview
Table 77. Eli Lilly Linagliptin Tablets Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2020-2025)
Table 78. Eli Lilly Linagliptin Tablets Product
Table 79. Eli Lilly Recent Developments/Updates
Table 80. Lupin Company Information
Table 81. Lupin Description and Business Overview
Table 82. Lupin Linagliptin Tablets Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2020-2025)
Table 83. Lupin Linagliptin Tablets Product
Table 84. Lupin Recent Developments/Updates
Table 85. Cipla Company Information
Table 86. Cipla Description and Business Overview
Table 87. Cipla Linagliptin Tablets Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2020-2025)
Table 88. Cipla Linagliptin Tablets Product
Table 89. Cipla Recent Developments/Updates
Table 90. Mankind Pharma Company Information
Table 91. Mankind Pharma Description and Business Overview
Table 92. Mankind Pharma Linagliptin Tablets Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2020-2025)
Table 93. Mankind Pharma Linagliptin Tablets Product
Table 94. Mankind Pharma Recent Developments/Updates
Table 95. Alkem Company Information
Table 96. Alkem Description and Business Overview
Table 97. Alkem Linagliptin Tablets Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2020-2025)
Table 98. Alkem Linagliptin Tablets Product
Table 99. Alkem Recent Developments/Updates
Table 100. Zydus Company Information
Table 101. Zydus Description and Business Overview
Table 102. Zydus Linagliptin Tablets Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2020-2025)
Table 103. Zydus Linagliptin Tablets Product
Table 104. Zydus Recent Developments/Updates
Table 105. Kyongbo Pharmaceutical Company Information
Table 106. Kyongbo Pharmaceutical Description and Business Overview
Table 107. Kyongbo Pharmaceutical Linagliptin Tablets Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2020-2025)
Table 108. Kyongbo Pharmaceutical Linagliptin Tablets Product
Table 109. Kyongbo Pharmaceutical Recent Developments/Updates
Table 110. Myungmoon Pharm Company Information
Table 111. Myungmoon Pharm Description and Business Overview
Table 112. Myungmoon Pharm Linagliptin Tablets Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2020-2025)
Table 113. Myungmoon Pharm Linagliptin Tablets Product
Table 114. Myungmoon Pharm Recent Developments/Updates
Table 115. Natco Pharma Company Information
Table 116. Natco Pharma Description and Business Overview
Table 117. Natco Pharma Linagliptin Tablets Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2020-2025)
Table 118. Natco Pharma Linagliptin Tablets Product
Table 119. Natco Pharma Recent Developments/Updates
Table 120. Torrent Pharmaceuticals Company Information
Table 121. Torrent Pharmaceuticals Description and Business Overview
Table 122. Torrent Pharmaceuticals Linagliptin Tablets Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2020-2025)
Table 123. Torrent Pharmaceuticals Linagliptin Tablets Product
Table 124. Torrent Pharmaceuticals Recent Developments/Updates
Table 125. Withus Pharmaceutical Company Information
Table 126. Withus Pharmaceutical Description and Business Overview
Table 127. Withus Pharmaceutical Linagliptin Tablets Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2020-2025)
Table 128. Withus Pharmaceutical Linagliptin Tablets Product
Table 129. Withus Pharmaceutical Recent Developments/Updates
Table 130. Hangzhou Minsheng Pharmaceutical Company Information
Table 131. Hangzhou Minsheng Pharmaceutical Description and Business Overview
Table 132. Hangzhou Minsheng Pharmaceutical Linagliptin Tablets Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2020-2025)
Table 133. Hangzhou Minsheng Pharmaceutical Linagliptin Tablets Product
Table 134. Hangzhou Minsheng Pharmaceutical Recent Developments/Updates
Table 135. Kelun Pharmaceutical Company Information
Table 136. Kelun Pharmaceutical Description and Business Overview
Table 137. Kelun Pharmaceutical Linagliptin Tablets Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2020-2025)
Table 138. Kelun Pharmaceutical Linagliptin Tablets Product
Table 139. Kelun Pharmaceutical Recent Developments/Updates
Table 140. Zhejiang Huahai Pharmaceutical Company Information
Table 141. Zhejiang Huahai Pharmaceutical Description and Business Overview
Table 142. Zhejiang Huahai Pharmaceutical Linagliptin Tablets Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2020-2025)
Table 143. Zhejiang Huahai Pharmaceutical Linagliptin Tablets Product
Table 144. Zhejiang Huahai Pharmaceutical Recent Developments/Updates
Table 145. Chengdu Brilliant Pharmaceutical Company Information
Table 146. Chengdu Brilliant Pharmaceutical Description and Business Overview
Table 147. Chengdu Brilliant Pharmaceutical Linagliptin Tablets Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2020-2025)
Table 148. Chengdu Brilliant Pharmaceutical Linagliptin Tablets Product
Table 149. Chengdu Brilliant Pharmaceutical Recent Developments/Updates
Table 150. Qilu Pharmaceutical Company Information
Table 151. Qilu Pharmaceutical Description and Business Overview
Table 152. Qilu Pharmaceutical Linagliptin Tablets Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2020-2025)
Table 153. Qilu Pharmaceutical Linagliptin Tablets Product
Table 154. Qilu Pharmaceutical Recent Developments/Updates
Table 155. CSPC Ouyi Pharmaceutical Company Information
Table 156. CSPC Ouyi Pharmaceutical Description and Business Overview
Table 157. CSPC Ouyi Pharmaceutical Linagliptin Tablets Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2020-2025)
Table 158. CSPC Ouyi Pharmaceutical Linagliptin Tablets Product
Table 159. CSPC Ouyi Pharmaceutical Recent Developments/Updates
Table 160. Yangtze River Pharmaceutical Company Information
Table 161. Yangtze River Pharmaceutical Description and Business Overview
Table 162. Yangtze River Pharmaceutical Linagliptin Tablets Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2020-2025)
Table 163. Yangtze River Pharmaceutical Linagliptin Tablets Product
Table 164. Yangtze River Pharmaceutical Recent Developments/Updates
Table 165. HEC Pharm Company Information
Table 166. HEC Pharm Description and Business Overview
Table 167. HEC Pharm Linagliptin Tablets Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2020-2025)
Table 168. HEC Pharm Linagliptin Tablets Product
Table 169. HEC Pharm Recent Developments/Updates
Table 170. Key Raw Materials Lists
Table 171. Raw Materials Key Suppliers Lists
Table 172. Linagliptin Tablets Distributors List
Table 173. Linagliptin Tablets Customers List
Table 174. Linagliptin Tablets Market Trends
Table 175. Linagliptin Tablets Market Drivers
Table 176. Linagliptin Tablets Market Challenges
Table 177. Linagliptin Tablets Market Restraints
Table 178. Research Programs/Design for This Report
Table 179. Key Data Information from Secondary Sources
Table 180. Key Data Information from Primary Sources
Table 181. Authors List of This Report
List of Figures
Figure 1. Product Picture of Linagliptin Tablets
Figure 2. Global Linagliptin Tablets Market Value Comparison by Type (2020-2031) & (US$ Million)
Figure 3. Global Linagliptin Tablets Market Share by Type: 2024 & 2031
Figure 4. Original Drug Product Picture
Figure 5. Generic Drug Product Picture
Figure 6. Global Linagliptin Tablets Market Value by Application (2020-2031) & (US$ Million)
Figure 7. Global Linagliptin Tablets Market Share by Application: 2024 & 2031
Figure 8. Hospital and Clinic
Figure 9. Retail Pharmacies
Figure 10. Other
Figure 11. Global Linagliptin Tablets Revenue, (US$ Million), 2020 VS 2024 VS 2031
Figure 12. Global Linagliptin Tablets Market Size (2020-2031) & (US$ Million)
Figure 13. Global Linagliptin Tablets Sales (2020-2031) & (K Units)
Figure 14. Global Linagliptin Tablets Average Price (US$/Unit) & (2020-2031)
Figure 15. Linagliptin Tablets Report Years Considered
Figure 16. Linagliptin Tablets Sales Share by Manufacturers in 2024
Figure 17. Global Linagliptin Tablets Revenue Share by Manufacturers in 2024
Figure 18. Global 5 and 10 Largest Linagliptin Tablets Players: Market Share by Revenue in Linagliptin Tablets in 2024
Figure 19. Linagliptin Tablets Market Share by Company Type (Tier 1, Tier 2, and Tier 3): 2020 VS 2024
Figure 20. Global Linagliptin Tablets Market Size by Region (US$ Million): 2020 VS 2024 VS 2031
Figure 21. North America Linagliptin Tablets Sales Market Share by Country (2020-2031)
Figure 22. North America Linagliptin Tablets Revenue Market Share by Country (2020-2031)
Figure 23. United States Linagliptin Tablets Revenue Growth Rate (2020-2031) & (US$ Million)
Figure 24. Canada Linagliptin Tablets Revenue Growth Rate (2020-2031) & (US$ Million)
Figure 25. Europe Linagliptin Tablets Sales Market Share by Country (2020-2031)
Figure 26. Europe Linagliptin Tablets Revenue Market Share by Country (2020-2031)
Figure 27. Germany Linagliptin Tablets Revenue Growth Rate (2020-2031) & (US$ Million)
Figure 28. France Linagliptin Tablets Revenue Growth Rate (2020-2031) & (US$ Million)
Figure 29. U.K. Linagliptin Tablets Revenue Growth Rate (2020-2031) & (US$ Million)
Figure 30. Italy Linagliptin Tablets Revenue Growth Rate (2020-2031) & (US$ Million)
Figure 31. Russia Linagliptin Tablets Revenue Growth Rate (2020-2031) & (US$ Million)
Figure 32. Asia Pacific Linagliptin Tablets Sales Market Share by Region (2020-2031)
Figure 33. Asia Pacific Linagliptin Tablets Revenue Market Share by Region (2020-2031)
Figure 34. China Linagliptin Tablets Revenue Growth Rate (2020-2031) & (US$ Million)
Figure 35. Japan Linagliptin Tablets Revenue Growth Rate (2020-2031) & (US$ Million)
Figure 36. South Korea Linagliptin Tablets Revenue Growth Rate (2020-2031) & (US$ Million)
Figure 37. India Linagliptin Tablets Revenue Growth Rate (2020-2031) & (US$ Million)
Figure 38. Australia Linagliptin Tablets Revenue Growth Rate (2020-2031) & (US$ Million)
Figure 39. China Taiwan Linagliptin Tablets Revenue Growth Rate (2020-2031) & (US$ Million)
Figure 40. Southeast Asia Linagliptin Tablets Revenue Growth Rate (2020-2031) & (US$ Million)
Figure 41. Latin America Linagliptin Tablets Sales Market Share by Country (2020-2031)
Figure 42. Latin America Linagliptin Tablets Revenue Market Share by Country (2020-2031)
Figure 43. Mexico Linagliptin Tablets Revenue Growth Rate (2020-2031) & (US$ Million)
Figure 44. Brazil Linagliptin Tablets Revenue Growth Rate (2020-2031) & (US$ Million)
Figure 45. Argentina Linagliptin Tablets Revenue Growth Rate (2020-2031) & (US$ Million)
Figure 46. Colombia Linagliptin Tablets Revenue Growth Rate (2020-2031) & (US$ Million)
Figure 47. Middle East and Africa Linagliptin Tablets Sales Market Share by Country (2020-2031)
Figure 48. Middle East and Africa Linagliptin Tablets Revenue Market Share by Country (2020-2031)
Figure 49. Turkey Linagliptin Tablets Revenue Growth Rate (2020-2031) & (US$ Million)
Figure 50. Saudi Arabia Linagliptin Tablets Revenue Growth Rate (2020-2031) & (US$ Million)
Figure 51. UAE Linagliptin Tablets Revenue Growth Rate (2020-2031) & (US$ Million)
Figure 52. Global Sales Market Share of Linagliptin Tablets by Type (2020-2031)
Figure 53. Global Revenue Market Share of Linagliptin Tablets by Type (2020-2031)
Figure 54. Global Linagliptin Tablets Price (US$/Unit) by Type (2020-2031)
Figure 55. Global Sales Market Share of Linagliptin Tablets by Application (2020-2031)
Figure 56. Global Revenue Market Share of Linagliptin Tablets by Application (2020-2031)
Figure 57. Global Linagliptin Tablets Price (US$/Unit) by Application (2020-2031)
Figure 58. Linagliptin Tablets Value Chain
Figure 59. Channels of Distribution (Direct Vs Distribution)
Figure 60. Bottom-up and Top-down Approaches for This Report
Figure 61. Data Triangulation
Figure 62. Key Executives Interviewed
